Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LEDIPASVIR\SOFOSBUVIR vs LEFLUNOMIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LEDIPASVIR\SOFOSBUVIR vs LEFLUNOMIDE: Safety Overview

Metric LEDIPASVIR\SOFOSBUVIR LEFLUNOMIDE
Total FAERS Reports 23,616 56,539
Deaths Reported 1,371 5,283
Death Rate 5.8% 9.3%
Hospitalizations 4,031 13,923
Average Patient Age 57.9 yrs 51.3 yrs
% Female Patients 42.9% 87.3%
FDA Approval Date N/A Apr 24, 2019
Manufacturer N/A Alembic Pharmaceuticals Inc.
Route N/A ORAL
Marketing Status N/A Prescription